"FDA Reverses Course And Will Review Moderna’s mRNA-Based Flu Shot"
"The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said Wednesday."











